699
Views
5
CrossRef citations to date
0
Altmetric
Review

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?

, ORCID Icon &
Pages 353-361 | Received 01 Oct 2019, Accepted 14 Jan 2020, Published online: 21 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Virginia Solitano, Tommaso Lorenzo Parigi, Elisa Ragaini & Silvio Danese. (2021) Anti-integrin drugs in clinical trials for inflammatory bowel disease (IBD): insights into promising agents. Expert Opinion on Investigational Drugs 30:10, pages 1037-1046.
Read now

Articles from other publishers (3)

Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad & Souhaila Al Khodor. (2022) Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 23:13, pages 6966.
Crossref
Charlotte D’Mello & Mark G. Swain. 2021. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes 205 236 .
Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese & Gionata Fiorino. (2020) New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?. Current Opinion in Pharmacology 55, pages 141-150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.